✦ LIBER ✦

Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors

✍ Scribed by Brigitte Tranchand; Gilles Catimel; Catherine Lucas; Marlis Sarkany; Gérard Bastian; Eric Evene; Jean-Paul Guastalla; Sylvie Négrier; Paul Rebattu; Arlette Dumortier; Maurice Foy; François Grossin; Béatrice Mazier; Marios Froudarakis; Nicolas Barbet; Michel Clavel; Claude Ardiet

Publisher: Springer
Year: 1998
Tongue: English
Weight: 222 KB
Volume: 41
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

✍ A. S. T. Planting; P. Sonneveld; A. van der Gaast; A. Sparreboom; M. E. L. van d 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 253 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.

✍ C.-P. Schneider; U. Merkel; U. Grübner; R. Kath; K. Höffken; A. Hoffmann 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 89 KB

A phase I and pharmacokinetics study of

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

✍ Josephia R. Muindi; Candace S. Johnson; Donald L. Trump; Renee Christy; Kristie 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 429 KB

A phase I dose escalation and pharmacoki

A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors

✍ E. Gabriela Chiorean; Srikar Malireddy; Anne E. Younger; David R. Jones; Mary-Ja 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

✍ R. O’Connor; M. O’Leary; J. Ballot; C. D. Collins; P. Kinsella; D. E. Mager; R. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 291 KB

A Phase I study to assess the safety, to

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB